Pathway Bioventures
Chicago, Illinoispathwaybioventures.com
Overview
Pathway Bioventures is a venture capital firm focusing on seed-stage investments in the life sciences sector. The company targets next-generation therapeutics, medical devices, and diagnostics, seeking to support exceptional teams that utilize innovative biotechnology to tackle significant unmet medical needs. By concentrating on advancements at the forefront of biology and engineering, Pathway Bioventures aims to foster the development of transformative healthcare solutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytospire Therapeutics | May 2026 | Series A | Co-investor |
| Nionyx Bio | Sep 2025 | Seed | Co-investor |
| Afference | Oct 2024 | Seed | Co-investor |
| Afference | Oct 2024 | Seed | Co-investor |
| Axonis Therapeutics | Oct 2024 | Series A | - |
Key People
Daniel Jacobs
Founder & Managing Partner
Matt Martin
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
